Next Article in Journal
Bare Iron Oxide Nanoparticles for Magnetic Harvesting of Microalgae: From Interaction Behavior to Process Realization
Next Article in Special Issue
Carbon-Based Fe3O4 Nanocomposites Derived from Waste Pomelo Peels for Magnetic Solid-Phase Extraction of 11 Triazole Fungicides in Fruit Samples
Previous Article in Journal
Biofunctionalized Lysophosphatidic Acid/Silk Fibroin Film for Cornea Endothelial Cell Regeneration
Previous Article in Special Issue
Magnesium and Nitrogen Co-Doped Mesoporous Carbon with Enhanced Microporosity for CO2 Adsorption
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 8
Issue 5
10.3390/nano8050291
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Activity of New Materials Based on Lavender and Basil Essential Oils and Hydroxyapatite

by
Daniela Predoi
1,*,
Simona Liliana Iconaru
1,
Nicolas Buton
2,
Monica Luminita Badea
3 and
Luminita Marutescu
4,5
1
National Institute of Materials Physics, 405 A Atomistilor Street, P.O. Box MG7, 077125 Magurele, Romania
2
HORIBA Jobin Yvon S.A.S., 6-18, Rue du Canal, 91165 Longjumeau CEDEX, France
3
University of Agronomic Sciences and Veterinary Medicine, Faculty of Horticulture, 59 Mărăşti Blvd., 011464 Bucharest, Romania
4
Microbiology Department, Faculty of Biology, University of Bucharest, 1–3 Portocalelor Lane, 77206 Bucharest, Romania
5
Earth, Environmental and Life Sciences Section, Research Institute of the University of Bucharest (ICUB), 91-95 Splaiul Independentei, 050095 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Nanomaterials 2018, 8(5), 291; https://doi.org/10.3390/nano8050291
Submission received: 28 March 2018 / Revised: 25 April 2018 / Accepted: 26 April 2018 / Published: 30 April 2018
(This article belongs to the Special Issue Preparation and Application of Hybrid Nanomaterials)
Browse Figures
Versions Notes

Abstract

:
This study presents, for the first-time, the results of a study on the hydrodynamic diameter of essential oils (EOs) of basil and lavender in water, and solutions of EOs of basil (B) and lavender (L) and hydroxyapatite (HAp). The possible influence of basil and lavender EOs on the size of hydroxyapatite nanoparticles was analyzed by Scanning Electron Microscopy (SEM). We also investigated the in vitro antimicrobial activity of plant EOs and plant EOs hydroxyapatite respectively, against Gram-positive bacteria (methicillin-resistant Staphylococcus aureus1144 (MRSA 1144) and S. aureus 1426) and Gram-negative bacteria (Escherichia coli ATCC 25922 and Escherichia coli ESBL 4493). From the autocorrelation function, obtained by Dynamic Light Scattering (DLS) measurements it was observed that basil yielded one peak at an average hydrodynamic diameter of 354.16 nm, while lavender yielded one peak at an average hydrodynamic diameter of 259.76 nm. In the case of HAp nanoparticles coated with basil (HApB) and lavender (HApL) essential oil, the aggregation was minimal. We found that the lavender EO exhibited a very good inhibitory growth activity (MIC values ranging from <0.1% for E. coli reference strain to 0.78% for S. aureus strains). The biological studies indicated that HapL material displayed an enhanced antimicrobial activity, indicating the potential use of HAp as vehicle for low concentrations of lavender EO with antibacterial properties. Flow cytometry analysis (FCM) allowed us to determine some of the potential mechanisms of the antimicrobial activities of EOs, suggesting that lavender EO was active against E. coli by interfering with membrane potential, the membrane depolarization effect being increased by incorporation of the EOs into the microporous structure of HAp. These findings could contribute to the development of new antimicrobial agents that are urgently needed for combating the antibiotic resistance phenomena.

1. Introduction

Recent advances in medicine and biotechnology have not been able to overcome the rapid and ongoing worldwide emergence and spread of drug resistant microorganisms. This fact has stimulated the search for new types of effective and nontoxic antimicrobial agents amongst natural compounds which are found in aromatic plants, and which have been previously used in cosmetics, folk medicine, and aromatherapy [1]. Nowadays, many plants possess great economic value, and it is estimated that approximately 700,000 species of tropical plants exhibit medicinal properties and can be used as antibacterial, antiviral, antifungal, antiallergic, anticarcinogenic and larvicidal agents [2,3]. Essential oils, which have been known for their perfume, flavor and preservative properties since antiquity, are aromatic oily liquids and can be obtained from different plant organs (flowers, buds, seeds, leaves, twigs, etc.) by expression, extraction, fermentation, enfleurage, and steam distillation [4,5]. It has been reported several times that some EOs possess antimicrobial properties [5,6,7,8], and due to the recent worldwide interest in “green” consumerism, the scientific interest regarding these substances has been revitalized [9,10]. Beyond their antibacterial properties [11], EOs have also been reported to exhibit antiviral [12], antimycotic [13], antioxigenic [14], antiparasitic [15], and insecticidal [16] properties.
The bactericidal properties of EOs vapors are presumed to have been investigated for the first time in 1881 by De la Croix [9]. Nevertheless, the use of EOs in medicine has become secondary to their uses as flavors and aromas in the 19th and 20th centuries [5]. Nowadays, the antibacterial properties of EOs and their components are exploited mostly in commercial products as dental root canal sealers [17], cosmetic preservatives [18], antiseptics [19], food packaging [20,21,22], etc. Although currently used in many commercial products due to their aromatic properties, EOs are widely known for their role in food safety and preservation [23,24,25,26,27,28]. Due to its biological properties and attractive aroma, lavender EO is widely used in the food industry [29,30,31,32,33]. Recent studies have reported the use of lavender in food industry for extending the quality and shelf life of bread [34]. Moreover, in their studies, Bensmira et al. have demonstrated that the incorporation of lavender oil into sunflower oil has a promising effected on the frying temperature of the oil [35]. In particular, it has been reported to demonstrate antimicrobial properties against a variety of microorganisms, especially Candida albicans, Escherichia coli and Staphylococcus aureus [36,37]. Due to its outstanding antimicrobial properties, lavender EO has also been investigated for use in strawberry packaging systems [38]. Sangsuwan et al. [38] demonstrated in their study that the overall quality of the fruit treated with lavender and red thyme EOs were maintained. Beyond that, the results revealed that lavender EO can extend the mold-free storage life of strawberries kept at 7 °C from 2 days (control) to 8 days. Over recent decades, anecdotal evidence has described the biologic activity of lavender EOs, but it is only recently that some of the claims have been scientifically investigated [37,39]. Another popular herb, basil, often referred as the “King of the herbs”, which belongs to the major oil-producing species, is widely utilized due to its economic, nutritional, industrial and medicinal importance [40]. Basil EO has been reported to exhibit antioxidant, antimicrobial and antitumor activities, due to its phenolic acids and aromatic compounds [41,42]. Recent studies have reported that different Eos, including those of lavender and basil, have antibacterial activities against gram positive bacteria, including Staphylococcus aureus, Bacillus species, and gram negative bacteria, namely Escherichia coli, Shigella flexneri, as well as pathogenic fungus, specifically Candida albicans [43,44,45,46]. Two of the most prevalent species of gram-positive and gram-negative bacteria that are responsible for very severe infections are Staphylococcus aureus and Escherichia coli. S. aureus is one of the most common Gram-positive organisms, and is responsible for a multitude of diseases, ranging from moderate skin infections and food poisoning to endocarditis and very severe bloodstream infections. E. coli is also a common nosocomial pathogen that causes urinary tract infections and enterocolitis. According to data from the Broad Institute in 2010, E. coli was responsible for 17.3% of of clinical infections requiring hospitalization, while S. aureus was accountable for 18.8% [47,48]. Due to the worldwide emergence of S. aureus E. coli strains which are resistant to conventional antibiotic therapy, there have been major concerns in the public health area invigorating the need for the development of new antimicrobial compounds. Hydroxyapatite is one of the most commonly materials used in the pharmaceutical and medical fields, due to its similarities to the human hard tissue, and its biocompatible properties. HAp has been utilized in biomaterial engineering and regenerative medicine, and was employed in the development of controlled drug delivery systems [49,50,51]. Besides its use in the medical field, HAp crystals are well known for their use in the food industry and agriculture. Initially HAp was utilized for softening drinking water, but after 1985, due to its remarkable properties for removing pollutants from water, HAp has been used for metal and nutrient recovery from wastewater systems [52,53]. Owing to its similarities with hard human tissue, HAp is currently being widely investigated for its possible biomedical applications as an antimicrobial agent. So far, studies have been undertaken involving HAp powders doped with several metal ions that are known to possess antimicrobial properties, such as silver, zinc, cerium [54,55,56,57], etc. In this context, the present work is focused on the use of hydroxyapatite as a carrier of Eos, in order to develop a new antimicrobial bioactive compound.
In this work, studies regarding the hydrodynamic diameters of basil and lavender EOs in water and of HAp nanoparticles coated with basil and lavender EOs (HApB and HApL) are presented for the first time. The antimicrobial activity of the newly-developed materials based on HAp nanoparticles (HAp-B and HAp-L) and plant EOs (B-Basil and L-Lavender) against Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria was also investigated.

2. Results and Discussions

Both Ocimum basilicum L. (basil or sweet basil) and Lavandula angustifolia Mill (lavender) are some of the world’s most cultivated varieties, due to their various applications in the food, cosmetics, and perfume industries, as well as their use in traditional medicine [58,59].
The most abundant components identified in basil and lavender EOs are presented in Table 1 and Table 2.
The high concentration of linalool in the samples indicates that basil EO is of chemotype A. The GC data emphasized that the majority of the compounds found in the samples were monoterpenes and sesquiterpenes. The results of the analysis revealed that the dominant components of the lavender EO samples were represented by the oxygenated monoterpenes group. In both the basil and lavender EOs GC/GCMS analyses, the rest of the identified constituents were present at under 0.5%; numerous compounds were identified as trace amounts. Although plant EOs have been utilized for over 6000 years, scientific research of them is currently limited to fundamental, phytochemical and biological research. The physico-chemical properties of plant EOs are not well understood. Their ability to self-aggregate in solution is also not completely understood.
Recently, particular attention has been paid to HAp as a result of the widening of application domains, such as its use in the preparation of biocompatible materials for dental and orthopedic applications, or use in the manufacture of pharmaceutical products in the food or fertilizer industries [60]. Structure, crystallinity, particle size or morphology play an important role in each of these applications. This research was focused on studying the structure and morphology of materials based on HAp and EOs. In this context, information on the structure and morphology of HAp synthesized prior to EOs coverage could be of particular importance in various applications in the pharmaceutical or food industries.
The X-ray diffraction (XRD) patterns of the obtained HAp powders, after centrifugation and drying at 100 °C in an oven, are shown in Figure 1. XRD results of HAp revealed that the peaks were perfectly matched with the standard ASTM data ICDD-PDF No. 9-432. All the peaks were assigned to the hexagonal Ca10(PO4)6(OH)2 in P63/m space group. The peaks of impurities, such as calcium hydroxide and calcium phosphates were not observed (Figure 1). The calculated values of lattice parameters “a” and “c” were 9.424 and 6.8839 Å, while for reference HAp (ICDD-PDF No. 9-432), the lattice parameters “a” and “c” were 9.418 and 6.8840 Å. The crystallite size of the prepared HAp obtained from Scherrer’s equation was 83.5 ± 1 nm. Similar results were also obtained in our previous studies [61,62]. According to A. Bigi et al. [62], the values of the parameters of the sides “a” and “c” are influenced both by the synthesis method, and the pH at which synthesis was achieved.
The morphology of the newly developed materials based on HAp and basil and lavender EOs (HApB and HApL) were studied using SEM. The influence of basil and lavender EOs on the size of HAp nanoparticles is presented in Figure 2a–c. The surface morphology did not change after the EO adsorption on the surface of the HAp nanoparticles. From the Scanning Electron Microscopy (SEM) images of the samples, the average size of the particles were determined by counting the number of particles (around 200). The particle distribution of HAp, HApB and HApL is presented in Figure 2d–f.
SEM images revealed that the particles were nanosized (less than 100 nm), with the size of nanoparticles decreasing from HAp to HApB and HApL. The mean particle sizes of HApB and HApL samples were evaluated at 76.8 ± 5 nm and 63.3 ± 6 nm, while the mean particle size of HAp was estimated to be 88.5 ± 3 nm.
Moreover, studies regarding the hydrodynamic behavior of HAp nanoparticles coated with basil and lavender EOs were also carried out. According to J. Bodycomb [63], the random fluctuations are interpreted in terms of the autocorrelation function (ACF), C(τ):
C(τ) = 1 + βexp(−2Γτ)
where the decay constant is Γ = Dmq2 and q = (4πn/λ)sin(θ/2), with Dm diffusion coefficient at infinite dilution, q scattering vector, n refractive index, λ wavelength, and θ scattering angle.
Finally, the hydrodynamic diameter obtained is the diameter of a sphere having the same translational diffusion coefficient as the particle. The hydrodynamic diameter was calculated using the Stokes-Einstein equation [54]:
Dh = kBT/3πƞDm
where Dh is the hydrodynamic diameter, kB the Boltzmann constant, T absolute temperature and ƞ the viscosity of the solvent.
An autocorrelation function of the scattered signal was obtained for all the studied samples (Figure 3).
Figure 3 revealed the experimental (markers and black line) and fitted (red line) autocorrelation function, obtained by DLS experiments on the basil and lavender EOs in water (Figure 3a,b) and HA coated with basil and lavender EOs in water (Figure 3c,d). A low scattering intensity was detected for lavender EOs in water (Figure 3b).
In Figure 4, the histogram obtained from the regularization fit of the autocorrelation was illustrated. It was observed from the autocorrelation function that basil yielded one peak at an average hydrodynamic diameter of 354.16 nm, while lavender yielded one peak at an average hydrodynamic diameter of 259.76 nm.
For the HApB and HApL samples, the average hydrodynamic diameters were established to be 265.63 and 257.76 nm respectively. The comparison of mean particle size estimated from SEM and DLS analysis is presented in Table 3. The difference between the particle diameters determined by the two methods is due to the fact that while SEM uses a primary electrons beam that is scanned over the surface of a specimen, whereas the Dynamic Light Scattering (DLS) measures the diffusion coefficient of the translational of the particles moving randomly in a liquid medium by Brownian motion. The diffusion coefficient is inversely proportional to the hydrodynamic diameter of the particles by the Stokes-Einstein equation [54].
The mean hydrodynamic diameter value of HAp was 273.86 ± 2 nm. The values obtained by SEM (88.5 ± 3) and XRD (83.5 ± 1 nm) analysis for mean diameter were considerably smaller than those obtained by DLS. Since there is a very large difference between the diameters obtained by SEM, XRD and DLS, this difference cannot be explained by taking into account the solvation layer of the particles. This behavior suggests the formation of suspension agglomerates. This mechanism could be explained as a result of the relative strength of hydrogen bonds that determine the formation of superaggregates, which immediately precipitate in the dispersion. It should be highlighted that all the samples demonstrated the same behavior.
The results obtained from DLS measurements in this study for all the analyzed samples are in good agreement with those previously presented by Lucio et al. [64]. Moreover, Wang et al. [65], in their recent studies regarding β-cyclodextrin and modified magnetic graphene oxide nanocomposites, confirmed our results. On the other hand, the materials based on HAp coated with basil and lavender EOs exhibited similar behavior to that of the β-cyclodextrin/HAp composites presented by Predoi et al. [66] in recent studies.
As a result of the increase in the incidence of antibiotic-resistant pathogens, particular attention was paid to the microstatic and microcidal actions, as well as to the spectrum of affected organisms. Exploitation of EOs obtained from medicinal plants for the treatment of microbial infections can lead to the development of new materials with antimicrobial properties. Since EOs are traditionally mainly used in aromatherapy [67] and massage [67], in the present study we have proposed the investigation of the antimicrobial activity of EOs in water solutions and EOs HAp solutions.
In the current context, when more and more bacterial strains adapt to new living conditions and develop an increased resistance to antibiotics, our intention to find and develop new materials based on EOs capable of stopping the development of bacteria, and even killing them, is an important step in this area.
The effect of plant EOs (basil and lavender) and HApB and HApL samples on cell viability was appraised against gram-positive (MRSA 1144 and S. aureus 1426) and gram-negative (E. coli ATCC 25922 and E. coli ESBL 4493) bacteria. One of the objectives of this research was to obtain significant information about the antibacterial effects of plant EOs, HApB and HApL. The qualitative screening of the antimicrobial properties was performed using an adapted diffusion method. The inhibition zone diameter results are presented in Table 4. The lavender EO inhibited the growth of all the tested bacterial strains, as indicated by the formation of growth inhibition zones around that ranged from 16 mm (against E. coli ESBL 4493) to 24 mm (against MRSA 1144). The HApL material was active against the tested bacterial strains, when compared to HAp alone. On the other hand, the basil EO and the HApB samples exhibited a lower inhibitory effect against the tested bacteria. The HAp materials had no effect on the growth of the selected bacteria.
Quantification of the antimicrobial activities of plant EOs and plant EO coated HAp was carried out using the microdilution method. The minimum inhibitory concentration (MIC) and values of the minimum bactericidal concentration were determined using the conventional plating method. The results are presented in Table 5 and Table 6.
The lavender EO displayed a stronger antimicrobial activity against the selected bacterial strains compared to the basil EO [68,69]. The Gram-negative bacteria, E. coli ATCC 25922 and E. coli ESBL 4493 were the most susceptible, with MBC values 0.19% for E. coli ESBL 4493 and of 0.1% for E. coli ATCC 25922 indicating a strong antimicrobial activity of lavender EO. The tested Gram-positive bacteria were less susceptible to the antibacterial action of the lavender EO. A possible explanation is that Gram-positive bacteria harbor a thick layer of peptidoglycan, which has the potential to inhibit the membrane-disrupting action of many of the EOs [68,69].
HAp alone lacked a noticeable antibacterial action, since the MBC values recorded against all bacteria were equal or greater than 5 mg/mL. However, significantly increased antimicrobial activity was detected for the HAp coated with lavender EO (HApL) against all the tested bacteria, as demonstrated by lower MIC values (ranging from 0.15 mg/mL in case of E. coli ATCC 25922 to 0.62 mg/mL (E. coli ESBL 4493). These results suggest that hydroxyapatite nanoparticles can be used as carriers for low concentration of lavender EO with antibacterial properties. Basil EO exhibited a lower antimicrobial effect in comparison with lavender EO; the recorded MIC and MBC values against the tested bacteria ranging between 25 and 50%. Also, the results indicated minor changes regarding the biological activity of HApB against the tested bacteria.
The flow cytometry (FCM)measurements were carried out for interrogation of the membrane potential of microbial cells treated with basil and lavender Eos, and the newly developed materials respectively, at ½ × MICs, using oxonol DiBAC4(3), as an indicator for membrane depolarization. The dye accumulates in the cytoplasm of depolarized bacteria and binds to intracellular proteins or membranes, thus resulting in an enhanced green fluorescence [70].
The intensity of the fluorescence (IF) of the bacterial cells treated with plant EOs alone were compared and are presented in Figure 5. The IF of the bacterial strains exposed to the plant EOs were similar with those of dimethyl sulfoxide (DMSO) treated cells, with the exception of E. coli ESBL 4493 cells treated with lavender EO. We observed a strong depolarization of bacterial plasmatic membrane, indicated by an increase in IF of at least three times in lavender EO treated cells compared with the solvent treated cells, at ½ × MIC. These results suggested that lavender EO was active against E. coli ESBL 4493 by interfering with the membrane potential. The basil EO caused a slight increase in IF, at ½ × MIC, in the case of E. coli ATCC 25922, MRSA1144 and S. aureus 1426, suggesting other possible antimicrobial mechanisms of action for this plant EO.
We found that the plasmatic membrane depolarization effect was increased by the incorporation of the basil EO into the structure of HAp for E. coli ATCC 25922 and MRSA 1144, as indicated by the increase of at least two times in the IF, when compared with HAp alone (Figure 6 and Figure 7). These results suggested stronger antimicrobial activity in the case of the newly developed materials. However, this effect was not detected against E. coli ESBL 4493 and S. aureus1426, when compared with HAp alone.
The incorporation of lavender EO in HAp did not interfere with the antimicrobial mode of action of the lavender EO, as indicated by the loss of membrane potential of E. coli ESBL 4493 treated cells, when comparing with HAp treated cells. No significant differences were detected for the S. aureus 1426 bacterial strain treated with HApL and HApB, when compared with the HAp alone, suggesting other possible antimicrobial mechanisms.
Lavender and basil EOs have been known and used since ancient times both in Greece and ancient Rome, as well as in the mysterious ancient Egypt [71,72,73,74], for perfume and medicine. Hippocrates and Theophrastus [75] talked about their beneficial effects on general state and mood. As claimed by T. Moon et al. [76] in their studies on “antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata”, lavender was one of the holy herbs used in the biblical Temple to prepare the holy essence. According to M. Lis-Balchin [77], lavender was also mentioned in Solomon’s song. The recent studies conducted by LG Matasyoh et al. [78] revealed that various plant EOs possess antibacterial activities against different gram negative (Escherichia coli, Salmonella enterica serotype Enteritidis) and gram positive bacteria (Staphylococcus aureus, Bacillus species), and fungi such as Candida albicans. In their previous studies, S. Dube et al. [79] reported the antifungal, physicochemical, and insect-repelling activity of the EO of Ocimum basilicum. Previous studies conducted by L. L. Silver and his collaborators [80] have shown increasing interest among researchers to discover and develop new antibiotics from medicinal plants.
In recent years, as a result of the increase in the number of drug resistant pathogens, special attention has been paid to the development of new antimicrobial agents. Plant EOs have been used since ancient times as natural remedies to combat pathogens. The antimicrobial action mechanisms include damaging the cell wall and membrane, alteration of proton motive force, and leakage of cytoplasmic contents [81]. Several approaches have been reported using plant EOs or components for prevention and control of human and animal infections. Also, many promising applications, such as pharmaceutical, food preservation systems, crop protection, are emerging [82]. However, toxicity, volatility, and lack of stability are currently limiting the transfer from research to practice. Antimicrobial coating has many advantages, including: efficient release of drugs, elevated stability, and protection from the interactions with the environment, decrease in volatility, enhancement of bioactivity, and reduced toxicity. In this context, we developed novel antimicrobial agents based on the incorporation of lavender and basil essential EOs into HAp. Our results regarding the antimicrobial activity of basil EO and of the newly-obtained material based on HAp and basil EO are in agreement with those previously reported by G. K. Sinha and B. C. Gulati [83]. In prior studies [84] concerning the antimicrobial and antifungal activity of plant EOs and some of their constituents, basil EOs were effective against a wide range of bacteria (e.g. S. aureus, E. coli, Salmonella enterica serotypes typhi and paratyphi, Shigella boydii and Proteus vulgaris).
The data presented in this paper regarding the antibacterial activity of lavender EO and newly developed lavender EO coated HAp are consistent with previous studies conducted by M. Lis-Balchin et al. [85,86] which have shown that lavender EO is active against many species of bacteria and fungi. The findings of this study also confirmed the previous research carried out by R. R. S. Nelson [87] on the in vitro activity of lavender essential oil against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium, at very low MIC values (less than 1%). Moreover, in the present study, we have demonstrated that the newly developed material based on HAp and lavender EO exhibits a strong antimicrobial property against representative Gram negative and Gram positive bacteria. In a recent study [88], the most effective calcium hydroxyapatite has been shown to be the microcrystalline hydroxyapatite concentrate extracted from the bones and or bone marrow of cattle, due to high protein and vitamin C levels. However, there is a risk that this calcium hydroxyapatite will be contaminated with various heavy metals such as lead, arsenic, or cadmium, from the animals feed. Moreover, as they come from cattle, there is the risk that the alfalfa, corn, or soybean have been genetically modified. As a result, the obtaining of hydroxyapatite by a simple and inexpensive method that can control purity [55,56,66] presents a particular advantage for the food industry. The possibility of covering hydroxyapatite with different molecules (such as EO) makes it more appealing to the food industry, and its range of uses could increase significantly. Moreover, starting from research on hydroxyapatite, the “nanoXIM·FoodPowder” product was created; it is a white powder of micrometric aggregates of hydroxyapatite suited for food products that cannot incorporate aqueous ingredients, like some dietary pills or specific types of gums [89].
As it can be seen from the presented results, the newly designed material, HApL showed significant antimicrobial properties against MRSA and E. coli ESBL bacterial strains. These results could significantly contribute to the development of new applications for cosmetic, pharmaceutical, medical or food industry. Their potential application in bone reconstruction could help reduce the number of postoperative infections after different implants. Moreover, the new materials obtained could play an important role in the food industry, and could be used to develop drugs that target bone health or dental hypersensitivity.

3. Materials and Methods

Plant EOs used in this study were represented by lavender EO (Lavandula angustifolia Sevastopolis) and basil EO (Ocimum basilicum L.). In order to obtain the plant materials for oil extraction, Ocimum basilicum L. whole plants were harvested at the beginning of the flowering stage (first week of August, 2015) from an independent farm situated in southeast Romania. The Lavandula angustifolia Sevastopolis plants were also obtained from a local farmer from southeast Romania in the initial flowering stage at the beginning of June 2015. The plants were dried, packed in paper bags, and stored in a cool and dry place. The two plant EOs were obtained by steam distillation, which allows the reduction of polar compound loss [89]. The lavender and basil EOs prepared according to R. Chanamai et al. [90] were added to the appropriate amount of water (4% ratio). The resulting liquid mixture was stirred at room temperature for 1 h, and then used for DLS and antimicrobial studies.
The resulting hydroxyapatite (2 mL), after washing and redispersion in deionized water [91], was added to the mixture of plant EO and water (4% ratio). The resulting solutions were stirred for 24 h at room temperature, after which they were analyzed by SEM and DLS studies. The hydroxyapatite (2 mL), after washing and redispersion in deionized water, was also analyzed by SEM and Energy Dispersive Spectroscopy (EDAX). Furthermore, the hydroxyapatite, after washing and redispersion in deionized water, was centrifuged and then dried in an oven at 80 °C, then analyzed by XRD.
To determine the crystal phase and crystallite size of prepared HAp powder, a Bruker D8 Advance diffractometer (Bruker, Karlsruhe, Germany) with nickel filtered CuK𝛼 (λ = 1.5418 Å) radiation and a high efficiency one dimensional detector (Lynx Eye type, Bruker, Karlsruhe, Germany), operated in integration mode, were used,. The data were collected from the 2θ range 20°–70°, with a step of 0.02° and 34 s measuring time per step. The crystallite size (D) of the prepared HAp was calculated by the Scherrer’s equation:
D = Kλ/βcosθ
where, K is a dimensionless shape factor, with a value close to unity, λ is the wavelength of Cu-Kα radiations (λ = 1.5405 Å), β is full width at half maxima of the most intense peak (211) and θ is the Bragg angle (in degrees).
The morphology of the newly developed materials was investigated by scanning electron microscopy (SEM), using a HITACHI S4500 microscope (Tokyo, Japan) equipped with an energy dispersive X-ray attachment (EDAX) (Tokyo, Japan).
Dynamic Light Scattering (DLS) measurements were conducted using a SZ-100 Nanoparticle Analyzer (HORIBA, Ltd., Kyoto, Japan) at 25 ± 1 °C. All samples were diluted in distilled water before analysis. The size distribution was obtained from the intensity autocorrelation function by regularization analysis implemented in the software package. Hydrodynamic diameters were calculated using the Stokes-Einstein equation [63].
The chemical composition of the oil samples were analyzed using the gas chromatography (GC) technique, using a Perkin Elmer gas chromatographer (PerkinElmer Inc, Waltham, MA, USA) equipped with a flame ionization detector (FID) (PerkinElmer Inc, Waltham, MA, USA) with two stationary fused silica columns (60 m × 0.25 mm × 0.25 μm film coating and 30 m × 0.32 mm × 0.25 μm film thickness). The working conditions were as follows: injector temperature 250 °C; the column temperature was increased linearly from 40 to 260 °C, with a rate of approximately 4 °C per minute; the carrier gas was H2; the amount of injected samples dissolved in methylene chloride (CH2Cl2) was 1 μL; and the injection volume was set at 1 mL/min with a split ratio of 1:30.
The GC/MS analysis of the essential oils was performed using a Pekin-Elmer Turbomass Quadrupole mass spectrometer (PerkinElmer Inc, Waltham, MA, USA). The spectrometer was fitted with a fused silica capillary column (60 m × 0.32 mm; 0.25 μm film coating). The operating conditions were the same as those described, or the analytical gas chromatography (GC). The mass spectrometry (MS) parameters were EI mode, with an ionization voltage of 70 eV. The compounds were identified using the using NIST and Wiley Registry 8 Edition mass database, n-alkalene (C9-C22) hydrocarbon series (Nile, Italy), and by comparing the mass spectra with MS literature [92,93,94]. The results of compound content were presented as relative area percent (%). The surface percentages obtained from the determination of standard chromatogram were used for the quantitative analysis.
Qualitative analysis of antimicrobial activity. The antibacterial assays were performed using one reference bacterial strain: E. coli ATCC 25922, and three clinical isolates from the collection of microorganisms in the Microbiology Department (Faculty of Biology, University of Bucharest): E. coli ESBL 4493 (an extended spectrum beta-lactamase producing strain), S. aureus 1426, methicillin-resistant S. aureus (MRSA) 1144. Microbial suspensions of 1.5 × 108 CFU/mL corresponding to a 0.5 McFarland density were prepared from 15 to 18 h solid cultures, obtained on TSA (tryptone soy agar). Standardized suspensions were inoculated onto Muller Hinton agar (MHA) plates by swabbing. The plant EOs were solubilized in DMSO (1:1 ratio). The HAp combinations, HApL and HApB, were also solubilized in DMSO at a final concentration of 10 mg/mL. From each of the solubilized material, a volume of 5 μL was placed directly, aseptically and distinctively onto the inoculated MHA plates. Agar plates were incubated at 37 °C for 18–24 h and inhibition zones formed were measured in mm [69,70,71,72]. A pure DMSO control was included with each test to ensure that microbial growth was not inhibited by DMSO itself. Tests were performed in duplicates.
Determining the minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values. The quantitative evaluation of antibacterial activities was performed using the microdilution broth method [69,95,96,97,98,99,100,101]. Each well of 96-well microtiter plate was aliquoted with 100 μL of Mueller-Hinton broth (MHB). One hundred microliters of MHB to the 12th well (sterility control), whereas MHB was added to 11th well (growth control). A volume of 100 μL of each plant EOs, HAp EOs combinations, and HAp dissolved in DMSO (as described above) were added to the first well, and a serial two-fold dilution was performed by transferring 100 μL of the suspension to the subsequent wells up to the 10th well; the final 100 μL of the suspension was discarded. Bacterial suspension of 1.5 × 108 CFU/mL was prepared starting from 18 to 24 h solid cultures obtained on TSA and diluted, to achieve a final inoculum density of 3 × 107 CFU and 3 × 105 CFU/mL. After incubation of the inoculated 96 well plates at 37 °C for 18–24 h, the minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values were determined using a conventional plating method. The lowest concentrations of material tested which visibly inhibited growth and respectively determined 99.9% growth inhibition upon subculturing on MHA plates after overnight incubation at 37 °C were used as the MIC and MBC values respectively. The results of the antimicrobial assays using an inoculum with a density of 3 × 107 CFU and 3 × 105 CFU/mL were similar.
Flow cytometric assay for detection of antimicrobial action. Fluorescence intensity, forward and side scatter values were determined with an Accuri C6 plus flow cytometer. The bacterial population was gated in the FSC-SSC dot plots referring to cell size and granularity. Evaluation of bacterial membrane potential was carried out with DiBAC4(3) dye (bis-(1,3-dibutylbarbituric acid) trimethineoxonol] (Invitrogen/Life Technologies, Carlsbad, CA, USA). The green fluorescence of the dye was detected in channel of fluorescence FITC. For flowcytometric analysis, after incubation at 37°C for 24 h, bacterial cells exposed to subinhibitory concentrations (½ × MICs) (100 μL) were transferred to 1.5 mL Eppendorf tubes and stained with membrane potential sensitive dye DiBAC4(3) (final concentration of 0.5 μg/mL) for 30 min at 37 °C, in the dark. Bacteria without treatment served as controls. The AccuriCFlow Plus software was used for data analysis.

4. Conclusions

Our studies presented in this work fall within the general endeavors to develop new materials with potential antimicrobial effects with applications in the food industry, pharmaceutical, or medical fields for the prevention and/or treatment of infectious diseases. The studies on the hydrodynamic diameter of basil and lavender EOs in water are presented for the first time. The average hydrodynamic diameters of basil and lavender EOs in water and basil and lavender EOs coated HAp nanoparticles were determined from the autocorrelation function. The DLS investigations showed that aggregation was minimal for all the studied samples. The morphology of the HAp nanoparticles coated with basil and lavender EOs determined by SEM studies indicated that the plant EOs coatings have influenced the size of the HAp nanoparticles, i.e., a decrease was observed from HAp to HApB and HApL. The antimicrobial studies showed very good antimicrobial activity for lavender EO, with MIC and MBC values of <0.1% for E. coli ESBL producing strain and 1.56% for MRSA. HAp coated with lavender EO displayed a significantly elevated antimicrobial effect, when compared with HAp alone, suggesting the potential use of HAp nanoparticles as carriers of low concentration of lavender EO with antibacterial properties. Flow cytometric measurements showed that at ½ × MICs, lavender EO, HApB and HApL disrupted the membrane potential of the treated bacteria, thus indicating a possible antimicrobial mechanism of action of the materials. The most significant diminution of growth inhibitory effect has been observed against E. coli. These findings could significantly contribute to the development of new antimicrobial strategies in the fight to combat infections following prosthetic implantation.

Author Contributions

Daniela Predoi conceived and designed the experiments; Nicolas Buton performed the DLS experiments; Luminita Marutescu and Monica Luminita Badea performed the in vitro experiments; Daniela Predoi, Nicolas Buton, Luminita Marutescu, Simona Liliana Iconaru and Monica Luminita Badea analyzed the data; Daniela Predoi wrote the paper; all authors have read the final version of the manuscript.

Funding

This research was funded by “UEFISCDI Romania”, grant numbers PN-III-P1-1.2-PCCDI-2017-0629 (Contract No. 43PCCDI) and PN-III-P2-2.1-BG-2016- 0369.

Acknowledgments

We thank A. Richard from the “Centre de Microscopie Electronique” of University of Orléans for assistance in SEM data acquisition.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Roller, S.; Ernest, N.; Buckle, J. The Antimicrobial Activity of High-Necrodane and Other Lavender Oils on Methicillin-Sensitive and -Resistant Staphylococcus aureus (MSSA and MRSA). J Altern. Complement. Med. 2009, 15, 275–279. [Google Scholar] [CrossRef] [PubMed]
  2. Valiakos, E.; Marselos, M.; Sakellaridis, N.; Constantinidis, T.; Skaltsa, H. Ethnopharmacological approach to the herbal medicines of the “Antidotes” in Nikolaos Myrepsos’ Dynameron. J. Ethnopharmacol. 2015, 163, 68–82. [Google Scholar] [CrossRef] [PubMed]
  3. Ba-Hamdan, A.H.A.; Aly, M.M.; Bafeel, S.O. Antimicrobial Activities and Phytochemical Analysis of the Essential Oil of Ocimum basilicum, Collected from Jeddah Region, Saudi Arabia. J. Microbiol. Res. 2014, 4, 1–9. [Google Scholar]
  4. Burt, S. Essential oils: Their antibacterial properties and potential applications in foods—A review. Int. J. Food. Microbiol. 2004, 94, 223–253. [Google Scholar] [CrossRef] [PubMed]
  5. Guenther, E. The Essential Oils; D. Van Nostrand: New York, NY, USA, 1948. [Google Scholar]
  6. Boyle, W. Spices and essential oils as preservatives. The American Perfumer and Essential Oil Review; Robbins Perfumer Co.: New York, NY, USA, 1955; Volume 66, pp. 25–28. [Google Scholar]
  7. Sakkas, H.; Papadopoulou, C. Antimicrobial Activity of Basil, Oregano, and Thyme Essential Oils. J. Microbiol. Biotechnol. 2017, 27, 429–438. [Google Scholar] [CrossRef] [PubMed]
  8. Freires, I.A.; Denny, C.; Benso, B.; de Alencar, S.M.; Rosalen, P.L. Antibacterial activity of essential oils and their isolated constituents against cariogenic bacteria: A systematic review. Molecules 2015, 20, 7329–7358. [Google Scholar] [CrossRef] [PubMed]
  9. Nychas, G.J.E. Natural antimicrobials from plants. In New Methods of Food Preservation; Gould, G.W., Ed.; Blackie Academic and Professional: London, UK, 1995; pp. 58–89. [Google Scholar]
  10. Tuley de Silva, K. (Ed.) A Manual on the Essential Oil Industry; United Nations Industrial Development Organization: Vienna, Austria, 1996. [Google Scholar]
  11. Deans, S.G.; Ritchie, G. Antibacterial properties of plant essential oils. Int. J. Food. Microbiol. 1987, 5, 165–180. [Google Scholar] [CrossRef]
  12. Bishop, C.D. Antiviral activity of the essential oil of Melaleuca alternifolia (Maiden and Betche) Cheel (tea tree) against tobacco mosaic virus. J. Essent. Oil Res. 1995, 7, 641–644. [Google Scholar] [CrossRef]
  13. Azzouz, M.A.; Bullerman, L.B. Comparative antimycotic effects of selected herbs, spices, plant components and commercial antifungal agents. J. Food Protect. 1982, 45, 1298–1301. [Google Scholar] [CrossRef]
  14. Juglal, S.; Govinden, R.; Odhav, B. Spice oils for the control of co-occurring mycotoxin-producing fungi. J. Food Protect. 2002, 65, 683–687. [Google Scholar] [CrossRef]
  15. Pandey, R.; Kalra, A.; Tandon, S.; Mehrotra, N.; Singh, H.N.; Kumar, S. Essential oil compounds as potent source of nematicidal compounds. J. Phytopathol. 2000, 148, 501–502. [Google Scholar] [CrossRef]
  16. Konstantopoulou, I.; Vassilopoulou, L.; Mavragani-Tsipidou, P.; Scouras, Z.G. Insecticidal effects of essential oils. A study of the effects of essential oils extracted from eleven Greek aromatic plants on Drosophila auraria. Experientia 1992, 48, 616–619. [Google Scholar] [CrossRef] [PubMed]
  17. Manabe, A.; Nakayama, S.; Sakamoto, K. Effects of essential oils on erythrocytes and hepatocytes from rats and dipalitoyl phophatidylcholine-liposomes. Jpn. J. Pharmacol. 1987, 44, 77–84. [Google Scholar] [CrossRef] [PubMed]
  18. Kunicka-Styczynska, A.; Sikora, M.; Kalemba, D. Antimicrobial activity of lavender, tea tree and lemon oils in cosmetic preservative systems. J. Appl. Microbiol. 2009, 107, 1903–1911. [Google Scholar] [CrossRef] [PubMed]
  19. Cox, S.D.; Mann, C.M.; Markham, J.L.; Bell, H.C.; Gustafson, J.E.; Warmington, J.R.; Wyllie, S.G. The mode of antimicrobial action of essential oil of Melaleuca alternifola (tea tree oil). J. Appl. Microbiol. 2000, 88, 170–175. [Google Scholar] [CrossRef] [PubMed]
  20. Kuorwel, K.K.; Cran, M.J.; Sonneveld, K.; Miltz, J.; Bigger, S.W. Essential Oils and Their Principal Constituents as Antimicrobial Agents for Synthetic Packaging Films. J. Food Sci. 2011, 76, R164–R177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Ribeiro-Santos, R.; Andrade, M.; Ramos de Melob, N.; Sanches-Silva, A. Use of essential oils in active food packaging: Recent advances and future trends. Trends Food Sci. Technol. 2017, 61, 132–140. [Google Scholar] [CrossRef]
  22. Atarés, L.; Chiralt, A. Essential oils as additives in biodegradable films and coatings for active food packaging. Trends Food Sci. Technol. 2016, 48, 51–62. [Google Scholar] [CrossRef]
  23. Danh, L.T.; Han, L.N.; Triet, N.D.A.; Zhao, J.; Mammucari, R.; Foster, N. Comparison of Chemical Composition, Antioxidant and Antimicrobial Activity of Lavender (Lavandula angustifolia L.) Essential Oils Extracted by Supercritical CO2, Hexane and Hydrodistillation. Food Bioprocess. Technol. 2013, 6, 3481–3489. [Google Scholar] [CrossRef]
  24. Dini, I. Chapter 14—Use of Essential Oils in Food Packaging. In Essential Oils in Food Preservation, Flavor and Safety; Academic Press: Cambridge, MA, USA, 2016; pp. 139–147. [Google Scholar]
  25. Echegoyen, Y.; Nerín, C. Performance of an active paper based on cinnamon essential oil in mushrooms quality. Food Chem. 2015, 170, 30–36. [Google Scholar] [CrossRef] [PubMed]
  26. Clemente, I.; Aznar, M.; Salafranca, J.; Nerín, C. Raman spectroscopy, electronic microscopy and SPME-GC-MS to elucidate the mode of action of a new antimicrobial food packaging material. Anal. Bioanal. Chem. 2017, 409, 1037–1048. [Google Scholar] [CrossRef] [PubMed]
  27. Gherardi, R.; Becerril, R.; Nerin, C.; Bosetti, O. Development of a multilayer antimicrobial packaging material for tomato puree using an innovative technology. LWT-Food Sci. Technol. 2016, 72, 361–367. [Google Scholar] [CrossRef]
  28. Wrona, M.; Bentayeb, K.; Nerín, C. A novel active packaging for extending the shelf-life of fresh mushrooms (Agaricus bisporus). Food Control 2015, 54, 200–207. [Google Scholar] [CrossRef]
  29. Preedy, V. (Ed.) Essential Oils in Food Preservation, Flavor and Safety; Academic Press: Cambridge, MA, USA, 2015. [Google Scholar]
  30. Peter, K.V. (Ed.) Handbook of Herbs and Spices; Woodhead Publishing Limited: Cambridge, UK, 2012. [Google Scholar]
  31. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol. 1999, 86, 985–990. [Google Scholar] [CrossRef] [PubMed]
  32. Porto, C.D.; Decorti, D.; Kikic, I. Flavour compounds of Lavandula angustifolia L. to use in food manufacturing: Comparison of three different extraction methods. Food Chem. 2009, 112, 1072–1078. [Google Scholar] [CrossRef]
  33. Kıvrak, Ş. Essential oil composition and antioxidant activities of eight cultivars of Lavender and Lavandin from western Anatolia. Ind. Crops Prod. 2018, 117, 88–96. [Google Scholar] [CrossRef]
  34. Vasileva, I.; Denkova, R.; Chochkov, R.; Teneva, D.; Denkova, Z.; Dessev, T.; Denev, P.; Slavov, A. Effect of lavender (Lavandula angustifolia) and melissa (Melissa Officinalis) waste on quality and shelf life of bread. Food Chem. 2018, 253, 13–21. [Google Scholar] [CrossRef] [PubMed]
  35. Bensmira, M.; Jiang, B.; Nsabimana, C.; Jian, T. Effect of Lavender and Thyme incorporation in sunflowerseed oil on its resistance to frying temperatures. Food Res. Int. 2007, 40, 341–346. [Google Scholar] [CrossRef]
  36. Cavanagh, H.M.A.; Wilkinson, J.M. Biological Activities of Lavender Essential Oil. Phytother. Res. 2002, 16, 301–308. [Google Scholar] [CrossRef] [PubMed]
  37. Roller, S. Natural Antimicrobials for the Minimal Processing of Foods; Woodhead Publishing Ltd/CRC Press: Cambridge, UK, 2003. [Google Scholar]
  38. Sangsuwan, J.; Pongsapakworawat, T.; Bangmo, P.; Sutthasupa, S. Effect of chitosan beads incorporated with lavender or red thymeessential oils in inhibiting Botrytis cinerea and their application in strawberry packaging system. LWT-Food Sci. Technol. 2016, 74, 14–20. [Google Scholar] [CrossRef]
  39. Zareen, A.; Gardezi, D.A.; Naeemullah, M.; Masood, M.S.; Tahira, R. Screening of Antibacterial Potential of Siam Queen, Holy Basil and Italian Basil Essential Oils. J. Med. Plant. Stud. 2014, 2, 63–68. [Google Scholar]
  40. Walsh, S.E.; Maillard, J.Y.; Russel, A.D.; Catrenich, C.E.; Charbonneau, D.L.; Bartolo, R.J. Activity and mechanism of action of selected biocidal agents on Gram-positive and negative bacteria. J. Appl. Microbiol. 2003, 94, 240–247. [Google Scholar] [CrossRef] [PubMed]
  41. Sienkiewicz, M.; Łysakowska, M.; Pastuszka, M.; Bienias, W.; Kowalczyk, E. The Potential of Use Basil and Rosemary Essential Oils as Effective Antibacterial Agents. Molecules 2013, 18, 9334–9351. [Google Scholar] [CrossRef] [PubMed]
  42. Sharafati-Chaleshtori, R.; Rokni, N.; Rafieian-Kopaei, M.; Drees, F.; Salehi, E. Antioxidant and Antibacterial Activity of Basil (Ocimum basilicum L.) Essential Oil in Beef Burger. J. Agric. Sci. Technol. 2015, 17, 817–826. [Google Scholar]
  43. Nakamura, C.V.; Nakamura, T.V.; Bando, E.; Melo, A.F.N.; Cortez, D.A.G.; Filho, B.P.D. Antibacterial activity of Ocimum gratissimum L. essential oil. Mem. Inst. Oswaldo Cruz 1999, 94, 675–678. [Google Scholar] [CrossRef] [PubMed]
  44. Matasyoh, L.G.; Matasyoh, J.C.; Wachira, F.N.; Kinyua, M.G.; Thairu, A.W.M.; Mukiama, T.K. Chemical composition and antimicrobial activity of the essential oil of Ocimum gratissimum L. growing in Eastern Kenya. Afr. J. Biotechnol. 2007, 6, 760–765. [Google Scholar]
  45. Chouhan, S.; Sharma, K.; Guleria, S. Antimicrobial Activity of Some Essential Oils—Present Status and Future Perspectives. Medicines 2017, 4, 58. [Google Scholar] [CrossRef] [PubMed]
  46. Raho, G.B.; Abouni, B. Escherichia coli and Staphylococcus aureus most common source of infection. In The Battle against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs; Méndez-Vilas, A., Ed.; Formatex Research Center: Badajoz, Spain, 2015. [Google Scholar]
  47. Tiemersma, E.W.; Bronzwaers, S.L.; Lyytikäinen, O.; Degener, J.E.; Schrijnemakers, P.; Bruinsma, N.; Monen, J.; Witte, W.; Grundman, H.; European Antimicrobial Resistance Surveillance System Participants. European antimicrobial resistance surveillance system participants: Methicillin-resistant Staphylococcus aureus in Europe. Emerg. Infect. Dis. 2004, 10, 1627–1633. [Google Scholar] [CrossRef] [PubMed]
  48. Kolmasn, J.; Krukowski, S.; Laskus, A.; Jurkitewicz, M. Synthetic hydroxyapatite in pharmaceutical applications. Ceram. Int. 2016, 42, 2472–2487. [Google Scholar] [CrossRef]
  49. Bose, S.; Tarafder, S.; Bandyopadhayay, A. Hydroxyapatite coatings for metallic implants. In Hydroxyapatite (HAp) for Biomedical Applications; Mucalo, M., Ed.; Woodhead Publishing Series in Biomaterials; Woodhead Publishing: Cambridge, UK, 2015; pp. 143–159. [Google Scholar]
  50. Ginebra, M.P.; Canal, C.; Espagnol, M.; Pastorino, D.; Montufar, E.B. Calcium phosphate cements as drug delivery materials. Adv. Drug Deliv. Rev. 2012, 64, 1090–1110. [Google Scholar] [CrossRef] [PubMed]
  51. Lema, J.M.; Martinez, S.S. (Eds.) Innovative Wastewater Treatment & Resource Recovery Technologies: Impacts on Energy, Economy and Environmen; IWA Publishing: London, UK, 2017. [Google Scholar]
  52. Giesen, A. Presentation: Precovery with the Crystalactor® process. Presented at the BALTIC 21 Phosphorus Recycling and Good Agricultural Management Practice, Berlin, Germany, 28–30 September 2009. [Google Scholar]
  53. Kolmas, J.; Groszyk, E.; Kwiatkowska-Różycka, D. Substituted Hydroxyapatites with Antibacterial Properties. BioMed Res. Int. 2014, 2014, 1–15. [Google Scholar] [CrossRef] [PubMed]
  54. Ciobanu, C.S.; Iconaru, S.L.; Chifiriuc, M.C.; Costescu, A.; Le Coustumer, P.; Predoi, D. Synthesis and Antimicrobial Activity of Silver-Doped Hydroxyapatite Nanoparticles. BioMed Res. Int. 2013, 2013. [Google Scholar] [CrossRef] [PubMed]
  55. Iconaru, S.L.; Prodan, A.M.; Buton, N.; Predoi, D. Structural Characterization and Antifungal Studies of Zinc-Doped Hydroxyapatite Coatings. Molecules 2017, 22, 604. [Google Scholar] [CrossRef] [PubMed]
  56. Ciobanu, C.S.; Popa, C.L.; Predoi, D. Cerium-doped hydroxyapatite nanoparticles synthesized by the co-precipitation method. J. Serb. Chem. Soc. 2016, 81, 433–446. [Google Scholar] [CrossRef]
  57. Marotti, M.; Piccaglia, R.; Giovanelli, E. Differences in Essential Oil Composition of Basil (Ocimum basilicum L.) Italian Cultivars Related to Morphological Characteristics. J. Agric. Food Chem. 1996, 44, 3926–3929. [Google Scholar] [CrossRef]
  58. Verma, R.S.; Rahman, L.U.; Chanotiya, C.S.; Verma, R.K.; Chauhan, A.; Yadav, A.; Singh, A.; Yadav, A.K. Essential oil composition of Lavandula angustifolia Mill. cultivated in the mid h ills of Uttarakhand, India. J. Serb. Chem. Soc. 2010, 75, 343–348. [Google Scholar] [CrossRef]
  59. Koutsopoulos, S. Synthesis and Characterization of Hydroxyapatite Crystals: A Review Study on the Analytical Methods. J. Biomed. Mater. Res. A 2002, 62, 600–612. [Google Scholar] [CrossRef] [PubMed]
  60. Predoi, D.; Iconaru, S.L.; Deniaud, A.; Chevallet, M.; Michaud-Soret, I.; Buton, N.; Prodan, A.M. Textural, Structural and Biological Evaluation of Hydroxyapatite Doped with Zinc at Low Concentrations. Materials 2017, 10, 229. [Google Scholar] [CrossRef] [PubMed]
  61. Popa, C.L.; Deniaud, A.; Michaud-Soret, I.; Guegan, R.; Motelica-Heino, M.; Predoi, D. Structural and biological assesement of zinc doped hydroxyapatite nanoparticles. J. Nanomater. 2016, 2016, 1062878. [Google Scholar] [CrossRef]
  62. Bigi, A.; Foresti, E.; Gandolfi, M.; Gazzano, M.; Roveri, N. Inhibiting effect of zinc on hydroxylapatite crystallization. J. Inorg. Biochem. 1995, 58, 49–58. [Google Scholar] [CrossRef]
  63. Bodycomb, J. HORIBA Scientific Home Page. Available online: http://www.horiba.com/us/particle (accessed on 20 November 2017).
  64. Lucio, D.; Irache, J.M.; Font, M.; Martínez-Ohárriz, M.C. Nanoaggregation of inclusion complexes of glibenclamide with cyclodextrins. Int. J. Pharm. 2017, 519, 263–271. [Google Scholar] [CrossRef] [PubMed]
  65. Wang, C.; Li, T.; Liu, Z.; Guo, Y.; Li, C.; Dong, C.; Shuang, S. An ultra-sensitive sensor based on β-cyclodextrin modified magnetic graphene oxide for detection of tryptophan. J. Electroanal. Chem. 2016, 781, 363–370. [Google Scholar] [CrossRef]
  66. Predoi, D.; Predoi, M.V.; Iconaru, S.L.; Ech Cherif El Kettani, M.; Leduc, D.; Prodan, A.M. Ultrasonic Measurements on β Cyclodextrin/Hydroxyapatite Composites for Potential Water Depollution. Materials 2017, 10, 681. [Google Scholar] [CrossRef] [PubMed]
  67. Graham, C. Complementary therapies: In the scent of a good night’s sleep. Nurs. Stand. 1995, 9, 21. [Google Scholar]
  68. Duarte, M.C.T.; Figueira, G.M.; Sartoratto, A.; Garcia Rehder, V.L.; Delarmelina, C. Anti-Candida activity of Brazilian medicinal plants. J. Ethnophramacol. 2005, 97, 305–311. [Google Scholar] [CrossRef] [PubMed]
  69. Saviuc, C.; Gheorghe, I.; Coban, S.; Drumea, V.; Chifiriuc, M.C.; Otilia Banu, O.; Bezirtzoglou, E.; Lazăr, V. Rosmarinus officinalis essential Oil and eucalyptol act as efflux pumps inhibitors and increase ciprofloxacin efficiency against Pseudomonas aeruginosa and Acinetobacter baumannii MDR strains. Rom. Biotechnol. Lett. 2016, 21, 11782–11790. [Google Scholar]
  70. Nuding, S.; Zabel, L.T. Detection, Identification, and Susceptibility Testing of Bacteria by Flow Cytometry. J. Bacteriol. Parasitol. 2013, S5. [Google Scholar] [CrossRef]
  71. Oxford University Press. Oxford English Dictionary, 2nd ed.; Note however that Upson and Andrews refer to Research on Bathing in the Roman Empire, and State that There Is No Mention of the Use of Lavender in Works on This Subject; Oxford University Press: Oxford, UK, 1989. [Google Scholar]
  72. Fernie, W.T. Herbal Simples; ASIN: B0014W4WNE; John Wright & Co.: Bristol, UK, 1895. [Google Scholar]
  73. Upson, T.; Andrews, S. The Genus Lavandula; Retrieved, 2004; Royal Botanic Gardens, Kew: London, UK, 2004; ISBN 9780881926422. [Google Scholar]
  74. Soule, J.A. Father Kino’s Herbs: Growing & Using Them Today; Tierra del Sol Institute Press: Tucson, AZ, USA, 2011. [Google Scholar]
  75. Arrowsmith, N. Essential Herbal Wisdom: A Complete Exploration of 50 Remarkable Herbs; Llewellyn Worldwide: Woodbury, MN, USA, 2009; pp. 1–576. ISBN 978-0-7387-1488-2. [Google Scholar]
  76. Moon, T.; Wilkinson, J.M.; Cavanagh, H.M. Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflat. Parasitol. Res. 2006, 99, 722–728. [Google Scholar] [CrossRef] [PubMed]
  77. Lis-Balchin, M. (Ed.) Lavender: The Genus Lavandula; Taylor and Francis: Abingdon, UK, 2002; ISBN 9780203216521. [Google Scholar]
  78. Mith, H.; Yayi-Ladékan, E.; Kpoviessi, S.D.S.; Bokossa, I.Y.; Moudachirou, M.; Daube, G.; Clinquart, A. Chemical Composition and Antimicrobial Activity of Essential Oils of Ocimum basilicum, Ocimum canum and Ocimum gratissimum in Function of Harvesting Time. JEOP. 2016, 19, 1413–1425. [Google Scholar] [CrossRef]
  79. Dube, S.; Upadhyay, P.D.; Tripathi, S.C. Antifungal, physicochemical, and insect-repelling activity of the essential oil of Ocimum basilicum. Can. J. Bot. 1989, 67, 2085–2087. [Google Scholar] [CrossRef]
  80. Silver, L.L.; Bostian, K.A. Discovery and development of new antibiotics: The problem of antibiotic resistance. Antimicrob. Agents Chemother. 1993, 37, 377–383. [Google Scholar] [CrossRef] [PubMed]
  81. Nicole, L.; Kavanaugh, N.L.; Katharina Ribbeck, K. Selected antimicrobial essential oils eradicate Pseudomonas spp. and Staphylococcus aureus biofilms. Appl. Environ. Microbiol. 2012, 78, 4057–4061. [Google Scholar]
  82. Bilia, A.R.; Guccione, C.; Isacchi, B.; Righeschi, C.; Firenzuoli, F.; Bergonzi, M.C. Essential Oils Loaded in Nanosystems: A Developing Strategy for a Successful Therapeutic Approach. Evid.-Based Complement. Altern. Med. 2014, 651593. [Google Scholar] [CrossRef] [PubMed]
  83. Sinha, G.K.; Gulati, B.C. Antibacterial and antifungal study of some essential oils and some of their constituents. Indian Perfum. 1990, 34, 126–129. [Google Scholar]
  84. Lis-Balchin, M.; Hart, S.; Deans, S.G.; Eaglesham, E. Comparison of the pharmacological and antimicrobial action of commercial plant essential oils. J. Herbs Spices Med. Plants 1996, 4, 69–86. [Google Scholar] [CrossRef]
  85. Lis-Balchin, M.; Deans, S.G.; Eaglesham, E. Relationship between bioactivity and chemical composition of commercial essential oils. Flavour. Fragr. J. 1998, 13, 98–104. [Google Scholar] [CrossRef]
  86. Nelson, R.R.S. In vitro activities of five plant essential olis against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 1997, 40, 305–306. [Google Scholar] [CrossRef] [PubMed]
  87. Braux, A. GMO 101—A Practical Guide to Genetically Engineered Food; Holistic Nutrition, Exacutive Chef and Culinary Nutritionist; Alain Braux International Publishing, I.I.C.: Lexington, KY, USA, 2014; ISBN 0.9842883-5-X. [Google Scholar]
  88. FLUIDINOVA Home Page. Available online: http://www.fluidinova.com/company-nano-hydroxyapatite-manufacturer-and-supplier (accessed on 20 November 2017).
  89. Masango, P. Cleaner production of essential oils by steam distillation. J. Clean. Prod. 2005, 13, 833–839. [Google Scholar] [CrossRef]
  90. Chanamai, R.; Horn, G.; McClements, D.J. Influence of Oil Polarity on Droplet Growth in Oil-in-Water Emulsions Stabilized by a Weakly Adsorbing Biopolymer or a Nonionic Surfactant. J. Colloid Interface. Sci. 2002, 247, 167–176. [Google Scholar] [CrossRef] [PubMed]
  91. Ciobanu, C.S.; Constantin, L.V.; Predoi, D. Structural and physical properties of antibacterial Ag-doped nano-hydroxyapatite synthesized at 100 °C. Nanoscale Res. Lett. 2011, 6, 613. [Google Scholar] [CrossRef] [PubMed]
  92. Adams, R.P.; Yanke, T. Material review: Kashmir Lavender Oil. Perfum. Flavor. 2007, 32, 40–44. [Google Scholar]
  93. Jennings, W.; Shibamoto, T. Qualitative Analysis of Flavor and Fragrance Volatile by Glass Capillary Gas Chromatography; Academic Press: New York, NY, USA, 1980. [Google Scholar]
  94. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/Quadruple Mass Spectroscopy; Allured Publishing Corporation: Carol Stream, IL, USA, 2001. [Google Scholar]
  95. Limban, C.; Chifiriuc, M.C. Antibacterial Activity of New Dibenzoxepinone Oximes with Fluorine and Trifluoromethyl Group Substituents. Int. J. Mol. Sci. 2011, 12, 6432–6444. [Google Scholar] [CrossRef] [PubMed]
  96. Limban, C.; Marutescu, L.; Chifiriuc, M.C. Synthesis, Spectroscopic Properties and Antipathogenic Activity of New Thiourea Derivatives. Molecules 2011, 16, 7593–7607. [Google Scholar] [CrossRef] [PubMed]
  97. Chifiriuc, M.C.; Palade, R.; Israil, A.M. Comparative analysis of disk diffusion and liquid medium microdillution methods fortesting the antibiotic susceptibility patterns of anaerobic bacterial strains isolated from intrabdominal infections. Biointerface Res. Appl. Chem. 2011, 1, 209–220. [Google Scholar]
  98. Rashid, M.A.; Ashraf, A.; Nazir, S.; Nazir, S.; Nadeem, R.; Iqbal, J.; Jabbar, S.; Ahmed, A.; Tareen, R.B. Chemical composition and biological (antioxidant, antimicrobial and haemolyitc) activities of essential oils of an endemic plant (Thymus linearis subsp. hedgei Jalas). Rom. Biotechnol. Lett. 2017, 22, 12560–12567. [Google Scholar]
  99. Atak, M.; Mavi, K.; Uremis, I. Bio-herbicidal effects of oregano and rosemary essential oils on germination and seedling growth of bread wheat cultivars and weeds. Rom. Biotechnol. Lett. 2016, 21, 11149–11159. [Google Scholar]
  100. Chifiriuc, M.C.; Stecoza, C.; Dracea, O.; Larion, C.; Israil, A.M. Antimicrobial activity of some new O-acyloximino-dibenzo[b,e]thiepins and O-acyloximino-dibenzo[b,e]thiepin-5,5-dioxides against planktonic cells. Rom. Biotechnol. Lett. 2010, 15, 5134–5139. [Google Scholar]
  101. Marutescu, L.; Limban, C.; Chifiriuc, M.C.; Missir, A.V.; Chirita, I.C.; Caproiu, M.T. Studies on the antimicrobial activity of new compounds containing thiourea function. Biointerface Res. Appl. Chem. 2011, 1, 236–241. [Google Scholar]
Nanomaterials 08 00291 g001 550
Figure 1. The X-ray diffraction (XRD) patterns of HAp (ICDD-PDF No. 9-432) and obtained HAp powders after centrifugation and drying at 100 °C in an oven.
Figure 1. The X-ray diffraction (XRD) patterns of HAp (ICDD-PDF No. 9-432) and obtained HAp powders after centrifugation and drying at 100 °C in an oven.
Nanomaterials 08 00291 g001
Nanomaterials 08 00291 g002 550
Figure 2. Scanning Eelectron Microscopy (SEM) images of the HAp (a), HApB (b) and HApL (c) samples. Size distributions of HAp (e), HApB (f) and HApL (g) samples.
Figure 2. Scanning Eelectron Microscopy (SEM) images of the HAp (a), HApB (b) and HApL (c) samples. Size distributions of HAp (e), HApB (f) and HApL (g) samples.
Nanomaterials 08 00291 g002
Nanomaterials 08 00291 g003 550
Figure 3. Experimental (markers) and fitted (red line) autocorrelation function obtained with DLS experiments for B (a); L (b); HApB (c) and HApL (d) samples.
Figure 3. Experimental (markers) and fitted (red line) autocorrelation function obtained with DLS experiments for B (a); L (b); HApB (c) and HApL (d) samples.
Nanomaterials 08 00291 g003
Nanomaterials 08 00291 g004 550
Figure 4. Particle size distributions of basil B (a); L (b); HApB (c) and HApL (d) obtained by fitting the experimental autocorrelation function.
Figure 4. Particle size distributions of basil B (a); L (b); HApB (c) and HApL (d) obtained by fitting the experimental autocorrelation function.
Nanomaterials 08 00291 g004
Nanomaterials 08 00291 g005 550
Figure 5. Stain indexes for each tested strain. The stain index is the ratio of the intensity of fluorescence measured in the FITC channel (530/30 nm), of bacteria treated with plant EO and DMSO respectively to that of untreated cells.
Figure 5. Stain indexes for each tested strain. The stain index is the ratio of the intensity of fluorescence measured in the FITC channel (530/30 nm), of bacteria treated with plant EO and DMSO respectively to that of untreated cells.
Nanomaterials 08 00291 g005
Nanomaterials 08 00291 g006 550
Figure 6. Stain indexes for each tested strain. The stain index is the ratio of the intensity of fluorescence measured in the FITC channel (530/30 nm), of bacteria treated with HAp, HApB and HApL to that of untreated cells.
Figure 6. Stain indexes for each tested strain. The stain index is the ratio of the intensity of fluorescence measured in the FITC channel (530/30 nm), of bacteria treated with HAp, HApB and HApL to that of untreated cells.
Nanomaterials 08 00291 g006
Nanomaterials 08 00291 g007 550
Figure 7. Overlays of control populations (not treated) onto exposed cells to HAp alone and HApB, respectively.
Figure 7. Overlays of control populations (not treated) onto exposed cells to HAp alone and HApB, respectively.
Nanomaterials 08 00291 g007
Table
Table 1. Chemical composition of Ocimum basilicum L. oils from southern Romania.
Table 1. Chemical composition of Ocimum basilicum L. oils from southern Romania.
No.Compound% of Total
Ocimum basilicum L.
1Linalool65.95
21,8 cineole10.57
3τ-cadinol4.74
4Eugenol3.76
5α-trans-bergamotene2.35
6α-terneol1.04
7Borneol0.9
8germacrene D1.38
9α-cadinene1.02
Identified from total area 91.71
Table
Table 2. Chemical composition of Lavandula angustifolia Sevastopolis oils from southern Romania.
Table 2. Chemical composition of Lavandula angustifolia Sevastopolis oils from southern Romania.
No.Compound% of Total
Lavandula angustifolia
1Linalool47.55
2Borneol8.52
3Camphor9.67
4terpinene-4-ol3.8
5Myrcene0.68
6Camphene0.56
7α-pinene0.54
8Sabinene0.5
9Limonene0.24
10β-phellandrene0.16
11α-terpinene0.06
121-8-cineole8.6
13linalool acetate3.75
14α-terpineol1.35
15Cryptone1.25
16geranyl acetate0.98
Identified from total area 79.61
Table
Table 3. Parameters comparison of mean particle size resulting from SEM and DLS analysis.
Table 3. Parameters comparison of mean particle size resulting from SEM and DLS analysis.
SampleSEM (nm)DLS (nm)
HAp88.5 ± 3273.86 ± 2
HApB76.8 ± 5265 ± 2
HApL63.3 ± 6257.76 ± 2
Table
Table 4. Screening of antimicrobial activities of plant EOs, HApB and HApL respectively, via an adapted diffusion method against Gram-positive and Gram-negative bacteria.
Table 4. Screening of antimicrobial activities of plant EOs, HApB and HApL respectively, via an adapted diffusion method against Gram-positive and Gram-negative bacteria.
Plant EOs and Plant EOs-HAp Combinations (Concentration)Inhibition Zone (mm)
Lavander EO HapL
(10 mg/mL)		BasilEOHApB
(10 mg/mL)		Hap
(10 mg/mL)		DMSO
Bacterial strain
E. coli ATCC 2592220 ± 115 ± 19 ± 27 ± 1*-*-
E. coli ESBL 449316 ± 0.510 ± 28 ± 16 ± 1*-*-
S. aureus 142625 ± 113 ± 210 ± 18 ± 1*-*-
MRSA 114424 ± 0.510 ± 27 ± 26 ± 1*-*-
* No inhibition zone observed.
Table
Table 5. Minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values determined based on conventional plating method for Plant EOs.
Table 5. Minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values determined based on conventional plating method for Plant EOs.
Plant EOs Bacterial StrainLavander EO (1:1)Basil EO (1:1)
MIC (%)MBC (%)MIC (%)MBC (%)
E. coli ATCC 25922<0.1<0.12540
E. coli ESBL 44930.190.193045
S. aureus 14260.781.564050
MRSA 11440.781.564550
Table
Table 6. Minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values determined based on conventional plating method for HAp, HApB and HApL.
Table 6. Minimum inhibitory concentration (MIC) values and minimum bactericidal concentration (MBC) values determined based on conventional plating method for HAp, HApB and HApL.
SampleHApLHApBHAp
Bacterial StrainMIC (mg/mL)MBC (mg/mL)MIC (mg/mL)MBC (mg/mL)MIC (mg/mL)MBC (mg/mL)
E. coli ATCC 259220.150.31555 5
E. coli ESBL 44930.620.62>5>5>5 >5
S. aureus 14260.310.625 >55 >5
MRSA 11440.310.625 >55 >5

Share and Cite

MDPI and ACS Style

Predoi, D.; Iconaru, S.L.; Buton, N.; Badea, M.L.; Marutescu, L. Antimicrobial Activity of New Materials Based on Lavender and Basil Essential Oils and Hydroxyapatite. Nanomaterials 2018, 8, 291. https://doi.org/10.3390/nano8050291

AMA Style

Predoi D, Iconaru SL, Buton N, Badea ML, Marutescu L. Antimicrobial Activity of New Materials Based on Lavender and Basil Essential Oils and Hydroxyapatite. Nanomaterials. 2018; 8(5):291. https://doi.org/10.3390/nano8050291

Chicago/Turabian Style

Predoi, Daniela, Simona Liliana Iconaru, Nicolas Buton, Monica Luminita Badea, and Luminita Marutescu. 2018. "Antimicrobial Activity of New Materials Based on Lavender and Basil Essential Oils and Hydroxyapatite" Nanomaterials 8, no. 5: 291. https://doi.org/10.3390/nano8050291

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop